A wound spacer device comprising multiple beads connected by non-absorbable suture material is disclosed. The device can be applied, for example, by a first responder to an injured individual, or can be applied by a trauma treatment facility, such as a Level 2 medical unit. In typical embodiments th
A wound spacer device comprising multiple beads connected by non-absorbable suture material is disclosed. The device can be applied, for example, by a first responder to an injured individual, or can be applied by a trauma treatment facility, such as a Level 2 medical unit. In typical embodiments the device allows for site-specific controlled elution of an antimicrobial agent, such as Tobramycin, including defined elution over a period of time, such as 48 or 72 hours.
대표청구항▼
1. A removable wound spacer packing device, said wound spacer packing device comprising: a plurality of beads arranged along a flexible textured polyamide connector material, each of said beads comprising: a polyamide core;a first layer outside said core, said first layer containing a bioactive agen
1. A removable wound spacer packing device, said wound spacer packing device comprising: a plurality of beads arranged along a flexible textured polyamide connector material, each of said beads comprising: a polyamide core;a first layer outside said core, said first layer containing a bioactive agent and a polymeric material derived from poly[vinylpyrrolidone], wherein said polymeric material is crosslinked to the core material;a second layer outside said first layer, said second layer comprising poly(butylmethacrylate) and poly(ethylene-co-vinyl acetate), wherein the second layer outside the core is crosslinked to the first layer outside the core; anda third layer outside said first layer, said third layer comprising poly(butylmethacrylate). 2. The removable wound spacer packing device of claim 1, wherein the second layer further comprises poly (vinylpyrrolidone). 3. The removable wound spacer packing device of claim 1, wherein the bioactive agent is selected from the group consisting of tobramycin, tobramycin sulfate, vancomycin, amikacin, gentamicin, kanamycin, neomycin, tigecycline, netilmicin, paromomycin, streptomycin, and apramycin and combinations thereof. 4. The removable wound spacer packing device of claim 1, wherein the bioactive agent comprises tobramycin sulfate. 5. The removable wound spacer packing device of claim 1, wherein the poly(ethylene-co-vinyl acetate) is selected from the group consisting of poly(ethylene-co-vinyl acetate) polymers having vinyl acetate concentrations of between about 10% and about 50% by weight. 6. The removable wound spacer packing device of claim 1, wherein the bioactive agent comprises a dose of about 500 to 2000 mcg per bead. 7. The removable wound spacer packing device of claim 1, wherein the bioactive agent has an elution profile such that at least 50 percent of the bioactive agent releases from the first, second, and third layers within 72 hours of placement within a wound. 8. The removable wound spacer packing device of claim 1, wherein the bioactive agent has an elution profile such that at least 65 percent of the bioactive agent releases from the first, second, and third layers within 72 hours of placement within a wound. 9. The removable wound spacer packing device of claim 1, wherein the beads are each molded to the connector material with sufficient strength so that the connector material will break under a tension load before the bond between the connector material and polyamide core breaks. 10. The removable wound spacer packing device of claim 1, wherein the cores of the plurality of beads contain barium sulfate. 11. The removable wound spacer packing device of claim 1, wherein only a portion of each bead of the plurality of beads contains barium sulfate. 12. The removable wound spacer packing device of claim 1, wherein the plurality of beads have an average spacing distance that is between 0.8 and 1.2 times the length of the average bead core diameter in contact with the connecting material. 13. The removable wound spacer packing device of claim 1, wherein the flexible polyamide connector material is coated with at least a first layer containing a bioactive agent and a polymeric material derived from poly[vinylpyrrolidone]. 14. The removable wound spacer packing device of claim 1, wherein the flexible polyamide connector material is substantially free of silicone. 15. The removable wound spacer packing device of claim 1, wherein the connector material comprises flexile braided suture material. 16. The removable wound spacer packing device of claim 1, wherein the beads are non-spherical. 17. The removable wound spacer packing device of claim 1, wherein the beads have an average volume between 15 and 8,000 cubic millimeters. 18. The removable wound spacer packing device of claim 1, wherein the device volume is from 1 to 150 cubic centimeters. 19. A removable wound spacer packing device, said wound spacer packing device comprising: a plurality of beads arranged along a flexible textured polyamide connector material, each of said polyamide beads comprising: a polyamide core containing barium sulfate;a first layer outside said core, said first layer containing a bioactive agent and a polymeric material derived from poly[vinylpyrrolidone] wherein said polymeric material is crosslinked to the core material;a second layer outside said first layer, said second layer comprising a material derived from poly(butylmethacrylate), poly(ethylene-co-vinyl acetate) and poly (vinyl pyrrolidone), wherein the second layer outside the core is crosslinked to the first layer outside the core; anda third layer outside said first layer, said third layer comprising poly(butylmethacrylate). 20. The removable wound spacer packing device of claim 19, wherein the bioactive agent is selected from the group consisting of tobramycin, tobramycin sulfate, vancomycin, amikacin, gentamicin, kanamycin, neomycin, tigecycline, netilmicin, paromomycin, streptomycin, and apramycin and combinations thereof. 21. The removable wound spacer packing device of claim 19, wherein the bioactive agent has an elution profile such that at least 65 percent of the bioactive agent elutes within 72 hours of placement within a wound. 22. The removable wound spacer packing device of claim 19, wherein the poly(ethylene-co-vinyl acetate) is selected from the group consisting of poly(ethylene-co-vinyl acetate) polymers having vinyl acetate concentrations of between about 10% and about 50% by weight. 23. The removable wound spacer packing device of claim 19, wherein the flexible polyamide connector material is coated with at least a first layer containing a bioactive agent and a polymeric material derived from poly[vinylpyrrolidone]. 24. A kit for treating a wound, the kit comprising: at least two removable wound spacer packing devices, each of said wound spacer packing devices comprising a plurality of beads arranged along a flexible textured polyamide connector material, each of said polyamide beads comprising: a polyamide core containing barium sulfate;a first layer outside said core, said first layer containing a bioactive agent and a polymeric material derived from poly[vinylpyrrolidone] wherein said polymeric material is crosslinked to the core material;a second layer outside said first layer, said second layer comprising a material derived from poly(butylmethacrylate), poly(ethylene-co-vinyl acetate) and poly (vinyl pyrrolidone), wherein the second layer outside the core is crosslinked to the first layer outside the core; anda third layer outside said first layer, said third layer comprising poly(butylmethacrylate); anda retaining device for holding the at least two removable wound spacer packing devices during storage and prior to application to a wound. 25. The kit for treating a wound of claim 24, wherein at least one of the wound spacer packing devices contains the bioactive agent tobramycin sulfate. 26. The kit for treating a wound of claim 25, wherein at least one of the wound spacer packing devices contains a gram positive bioactive agent. 27. The removable wound spacer packing device of claim 19, wherein the textured suture material comprises braided suture material. 28. The removable wound spacer packing device of claim 24, wherein the textured suture material comprises braided suture material.
Bachynsky Maria O. (Nutley) Infeld Martin H. (Upper Montclair) Shah Navnit (Clifton) Unowsky Joel (Livingston NJ), Absorption enhancement of antibiotics.
Alexander Harold (Short Hills NJ) Parsons John R. (Perth Amboy NJ) Strauchler Irving D. (Irvington NJ) Weiss Andrew B. (Short Hills NJ), Bio-absorbable composite tissue scaffold.
Yi, Chin-Feng; Gosiewska, Anna; Roweton, Susan, Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering.
Calhoun Jason H. (Galveston TX) Mader Jon T. (Galveston TX), Biodegradable antibiotic implants and methods of their use in treating and preventing infections.
Tuan Rocky S. (Chester Springs PA) Lin Sheldon S. (Philadelphia PA), Biodegradable drug delivery system for the prevention and treatment of osteomyelitis.
Gross Albert (Frankfurt am Main DT) Schaefer Roland (Friedrichsdorf ; Taunus DT) Reiss Siegfried (Bad Homburg DT), Bone cement compositions containing gentamycin.
Posey-Dowty Jessica (Kingsport TN) Higham Paul A. (Ringwood NJ) Arroyo Nestor A. (East Windsor NJ) Stark Casper F. (Pompton Lakes NJ), Bone cement for sustained release of substances.
Posey-Dowty Jessica D. (Bogota NJ) Higham Paul A. (Ringwood NJ) Arroyo Nestor (East Windsor NJ) Stark Casper F. (Pompton Lakes NJ), Bone cement for sustained release of substances.
Cho Se Hyun (Da-dong 608 Hyundai Apartment 277 Chilam-dong Chinju-city Kyeongsangnam-do KRX 660-702 ), Cement bead composition for orthopaedic surgery and its manufacturing process.
Tsukada Masuhiro,JPX ; Shirata Akira,JPX ; Hayasaka Sho Ji,JPX, Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore.
Errede Louis A. (North Oaks MN) Stoesz James D. (St. Paul MN) Winter ; deceased George D. (late of St. Paul MN by Jenny Upton ; personal representative), Composite wound dressing.
Donald G. Wallace ; George H. Chu ; Jacqueline Anne Schroeder, Compositions and systems for forming high strength medical sealants, and associated methods of preparation and use.
Laurencin Cato T. (Somerville MA) Lucas Paul A. (Macon GA) Syftestad Glenn T. (Sacramento CA) Domb Abraham (Baltimore MD) Glowacki Julie (Jamaica Plan MA) Langer Robert S. (Newton MA), Delivery system for controlled release of bioactive factors.
Truong, Myhanh T.; Pournoor, Kaveh; Choi, Hye-ok; Velasquez, David J.; Ferber, Richard H.; Bernatchez, Stephanie F., Delivery systems using preformed biodegradable polymer compositions and methods.
DeCrosta Mark T. (Plainsboro NJ) Jain Nemichand B. (Monmouth Junction NJ) Rudnic Edward M. (Kendall Park NJ), Drug delivery systems including novel interpenetrating polymer networks and method.
Tang Regianld T. (Warren NJ) Mares Frank (Whippany NJ) Boyle ; Jr. William J. (Parsippany NJ) Chiu Tin-Ho (Millburn NJ) Patel Kundanbhai M. (Landing NJ), Medical devices fabricated from copolymers having recurring carbonate units.
Finnicum Douglas S. (Webster NY) Pegoni Jack A. (Brockport NY) Story Thomas E. (Penfield NY), Method and apparatus for use in bead coating a web with liquid composition.
Holroyd Eric (Knutsford GB2) Wright Anthony R. (Southport GBX), Method for constructing a bead reinforcement with alternate windings of polymeric material and axially spaced apart wind.
Scott Christopher P., Methods and apparatus for delivering antibiotic powders into the femoral canal for the reduction of orthopaedic sepsis during total hip arthroplasty.
Rees Riley S. ; Marcelo Cynthia ; Adamson Belinda ; Rhodes Lenore ; Marchant Beverly ; Lindblad William ; Gilmont Robert ; Garner Warren ; Zuccaro Cynthia ; Taddonio Thomas E., Methods and compositions for the treatment of wounds.
Hanker Jacob S. (Chapel Hill NC) Terry Bill C. (Chapel Hill NC) Ambrose Wallace W. (Chapel Hill NC) Lupton Cecel R. (Chapel Hill NC), Plaster of Paris as a bioresorbable scaffold in implants for bone repair.
Wahlig Helmut (Darmstadt DEX) Dingeldein Elvira (Dreieich DEX) Rothe Johannes (Rossdorf DEX) Stille Wolfgang (Frankfurt DEX), Process for implanting a medicament depot.
Pietsch Hanns (Hamburg DEX) Hohmann Volker (Norderstedt DEX) Eckloff Willi (Hamburg DEX), Process for the preparation of a powder mixture for surgical use.
Ashman, Arthur; Bruins, Paul F., Process of making implantable prosthesis material of modified polymeric acrylic (PMMA) beads coated with PHEMA and barium sulfate.
Turkov Jaroslava (CeskBrod CSX) Stamberg Jir (Prague CSX), Proteolytic, dry biopolymeric composition for treatment of wounds, and method of using same.
Ducheyne Paul (Bryn Mawr PA) Topoleski L. D. Timmie (Philadelphia PA) Cuckler John M. (Haverford PA), Reinforced bone cement, method of production thereof and reinforcing fiber bundles therefor.
Tsuru Sumiaki (Tokyo JPX) Tsugita Masashi (Tokorozawa JPX) Takasaki Ken (Tokyo JPX) Yokoo Akihiko (Tokyo JPX) Ichitsuka Takeshi (Tokyo JPX), Slow release drug delivery granules and process for production thereof.
Rees Riley S. ; Marcelo Cynthia ; Adamson Belinda ; Rhodes Lenore ; Marchant Beverly ; Lindblad William ; Gilmont Robert ; Garner Warren ; Zuccaro Cynthia ; Taddonio Thomas E., System for the treatment of wounds.
Setterstrom, Jean A.; Tice, Thomas R.; Jacob, Elliot; Reid, Robert H.; van Hamont, John; Boedecker, Edgar C.; Jeyanthi, Ramassubbu; Friden, Phil; Roberts, F. Donald; McQueen, Charles E.; Bhattacharje, Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix.
Setterstrom Jean A. ; Van Hamont John E. ; Reid Robert H. ; Jacob Elliot ; Jeyanthi Ramasubbu ; Boedeker Edgar C. ; McQueen Charles E. ; Jarboe Daniel L. ; Cassels Frederick ; Brown William ; Thies C, Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix.
Errede Louis A. (North Oaks MN) Stoesz James D. (St. Paul MN) Upton Jenny (Bridgend GB7), Water-swellable composite sheet of microfibers of PTFE and hydrophilic absorptive particles.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.